Dupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis ...Middle East

Dupixent significantly reduced itch and skin lesions compared to placebo in direct-to-Phase 3 program consisting of two pivotal trials About 75,000 adults in the U.S. living with prurigo nodularis are most in need of new treatment options Approval represents the second dermatology...

Read More Details
Finally We wish PressBee provided you with enough information of ( Dupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis )

Also on site :

• Lou Christie, “Lightnin’ Strikes” and “Rhapsody in the Rain” Singer, Dies at 82
• Detained Afghan’s legal entry into U.S. was ‘improvident,’ government argues
• Legendary '80s Metal Band Performs Fan-Favorite for First Time in 20 Years: 'Sounding Great'